August 8th 2025
Solutions are emerging to manage advanced modalities and evolving regulatory requirements for viral clearance.
Gritgen Therapeutics Launches Commercial GMP Facility in China
October 11th 2023The construction of Gritgen’s GMP facility strictly adheres to the global current GMP (CGMP) standards and complies with the regulatory guidelines of authoritative agencies including the National Medical Products Administration (NMPA), FDA, and the European Medicines Agency (EMA).